Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sopharma AD Earnings Release 2024

Apr 22, 2024

2543_rns_2024-04-22_b3f7bbc0-9646-4ac0-b4e3-4d9c8a69821a.pdf

Earnings Release

Open in viewer

Opens in your device viewer

Current report № 21/ 2024 Dated April 22, 2024

NOTIFICATION

"Sopharma" AD (the Company) notifies that for March 2024 the Company recorded a decrease in sales of 24% compared to the same month of the previous year, incl. 8% decrease in domestic sales and 32% decrease in export sales, mainly due to destabilizing market dynamics on the main export destinations.

From the beginning of 2024, the Company recorded a decrease in sales of 11%, incl. 1% decrease of domestic sales and 16% decrease in export sales.

Ognian Donev